These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 23611687

  • 1. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
    Valença GT, Glass PG, Negreiros NN, Duarte MB, Ventura LM, Mueller M, Oliveira-Filho J.
    Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
    [Abstract] [Full Text] [Related]

  • 2. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
    Joutsa J, Martikainen K, Vahlberg T, Kaasinen V.
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
    [Abstract] [Full Text] [Related]

  • 3. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
    Poletti M, Logi C, Lucetti C, Del Dotto P, Baldacci F, Vergallo A, Ulivi M, Del Sarto S, Rossi G, Ceravolo R, Bonuccelli U.
    J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
    Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Brefel-Courbon C, Montastruc JL, Rascol O.
    Clin Neuropharmacol; 2012 Oct; 35(6):261-5. PubMed ID: 23123689
    [Abstract] [Full Text] [Related]

  • 5. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
    Ávila A, Cardona X, Martín-Baranera M, Bello J, Sastre F.
    J Neurol Sci; 2011 Nov 15; 310(1-2):197-201. PubMed ID: 21683375
    [Abstract] [Full Text] [Related]

  • 6. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
    Carrière N, Kreisler A, Dujardin K, Destée A, Defebvre L.
    Rev Neurol (Paris); 2012 Feb 15; 168(2):143-51. PubMed ID: 22129474
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The relationship between impulsivity and impulse control disorders in Parkinson's disease.
    Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A.
    Mov Disord; 2008 Feb 15; 23(3):411-5. PubMed ID: 18067187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC, López-Azcárate J, Garcia-Garcia D, Alegre M, Toledo J, Valencia M, Guridi J, Artieda J, Obeso JA.
    Brain; 2011 Jan 15; 134(Pt 1):36-49. PubMed ID: 21059746
    [Abstract] [Full Text] [Related]

  • 17. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr 15; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.